Publikationen

Multiple immunolabeling with antibodies from the same host species in combination with tyramide signal amplification.

Buchwalow I, Samoilova V, Boecker W, Tiemann M.
Acta Histochem. 2018 May 5. pii: S0065-1281(18)30039-4. doi: 10.1016/j.acthis.2018.05.002.
PMID: 29739626

Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in Europe

Keppens C, Palma JF, Das PM, Scudder S, Wen W, Normanno N, van Krieken JH, Sacco A, Fenizia F, Gonzalez de Castro D, Hönigschnabl S, Kern I, Lopez-Rios F, Lozano MD, Marchetti A, Halfon P, Schuuring E, Setinek U, Sorensen B, Taniere P, Tiemann M, Vosmikova H, Dequeker EMC.
J Mol Diagn. 2018 Jul;20(4):483-494. doi: 10.1016/j.jmoldx.2018.03.006. Epub 2018 Apr 26.
PMID: 29704571

Tryptase as a polyfunctional component of mast cells.

Atiakshin D, Buchwalow I, Samoilova V, Tiemann M.
Histochem Cell Biol. 2018 Mar 12. doi: 10.1007/s00418-018-1659-8.
PMID: 29532158

LIN28B enhanced tumorigenesis in an autochthonous KRASG12V-driven lung carcinoma mouse model

Meder L, König K, Dietlein F, Macheleidt I, Florin A, Ercanoglu MS, Rommerscheidt-Fuss U, Koker M, Schön G, Odenthal M, Klein F, Büttner R, Schulte JH, Heukamp LC, Ullrich RT.
Oncogene. 2018 May;37(20):2746-2756. doi: 10.1038/s41388-018-0158-7. Epub 2018 Mar 5.
PMID: 29503447

Personalized therapy based on sequential molecular analysis leads to 30 months of survival in a patient with diffuse unresectable gastric linitis plastica

Mahjoubi L, Cecchi F, Massard C, Calabro F, Gazzah A, Bahleda R, Jamme P, Gelli M, Goere D, Lacroix L, Adam J, Heukamp L, Trenta P, Hembrough T, Soria JC, Sternberg C, Ducreux M.
Tumori. 2018 Mar 1:300891618763215. doi: 10.1177/0300891618763215. [Epub ahead of print]
PMID: 29714649

Identification of autofluorescent cells in human angioimmunoblastic T-cell lymphoma.

Buchwalow I, Atiakshin D, Samoilova V, Boecker W, Tiemann M.
Histochem Cell Biol. 2018 Feb;149(2):169-177. doi: 10.1007/s00418-017-1624-y. Epub 2017 Dec 2.
PMID: 29197996

Interlaboratory concordance of PD-L1 immunohistochemistry for non-small-cell lung cancer.

Scheel AH, Baenfer G, Baretton G, Dietel M, Diezko R, Henkel T, Heukamp LC, Jasani B, Jöhrens K, Kirchner T, Lasitschka F, Petersen I, Reu S, Schildhaus HU, Schirmacher P, Schwamborn K, Sommer U, Stoss O, Tiemann M, Warth A, Weichert W, Wolf J, Büttner R, Rüschoff J.
Histopathology. 2018 Feb;72(3):449-459. doi: 10.1111/his.13375. Epub 2017 Nov 21.
PMID: 28851100

Poster

Die MYD88 L265P-Mutation: Ein Werkzeug für die Differentialdiagnose von indolenten Lymphomen mit überlappenden klinisch-pathologischen Eigenschaften? Michael Preukschas Marina Lebherz, Cora Hallas, Markus Tiemann. Jahrestagung der Deutschen Gesellschaft für Hämatologie und Onkologie, 10.-14. Oktober 2014 Hamburg, Germany

Tumor-infiltrierende Lymphozyten in kolorektalen Adenokarzinomen:  Die Entwicklung der Immunantwort in den verschiedenen Tumorstadien. Merle Stamm, Cora Hallas, Markus Falk, Markus Tiemann. Jahrestagung der Deutschen Gesellschaft für Hämatologie und Onkologie, 10.-14. Oktober 2014 Hamburg, Germany

Distribution of driver mutations in a northern German cohort of melanoma patients and limitations of different methods for BRAF testing. Markus Falk, Tobias Berg, Hans-Joachim Schulze, Michael Fluck, Markus Tiemann 8th World Congress of Melanoma, July 17–20 2013, Hamburg, Germany

Incidence of molecular targets (EGFR-mutation, EML4-Alk, BRAF and KRAS) in metastatic NSCLC in a certified lung cancer hospital. Volker Halbfass, Markus Falk, Regina Prenzel, Hans-Georg Dercken, Douglas Scriba, Markus Tiemann, Frank Griesinger 14th Conference of Lung Cancer, 3-7 July 2011, Amsterdam, Netherlands

Various Mutations In JAK2 Exon 12 Induce Divergent Bone Marrow Alterations Hallas C, Schulte C, Heidorn K, Tiemann M 53 ASH Annual Meeting and Exposition 2011, Abstract 4096

to top icon